| scholarly article | Q13442814 |
| P2093 | author name string | C L Chen | |
| N Raab-Traub | |||
| R H Sadler | |||
| I J Su | |||
| H C Hsieh | |||
| D M Walling | |||
| P2860 | cites work | EBV gene expression in an NPC-related tumour. | Q33576708 |
| Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells | Q33929593 | ||
| Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma | Q33937673 | ||
| VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA | Q33971399 | ||
| Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site | Q35616566 | ||
| A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome | Q36344649 | ||
| Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts | Q36696963 | ||
| Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. | Q36697762 | ||
| Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes | Q36698199 | ||
| Two related Epstein-Barr virus membrane proteins are encoded by separate genes | Q36780955 | ||
| Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes | Q36782491 | ||
| Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo | Q36822172 | ||
| Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. | Q36904686 | ||
| Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye | Q36927515 | ||
| Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia | Q37111825 | ||
| Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site | Q37552683 | ||
| U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2 | Q37579511 | ||
| Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis | Q40751741 | ||
| T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections | Q40787633 | ||
| A Transformation-Incompetent, Nuclear Antigen 2-Deleted Epstein-Barr Virus Associated with Replicative Infection | Q41685995 | ||
| Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China | Q41729450 | ||
| Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells | Q42010316 | ||
| The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation | Q43610021 | ||
| Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease | Q43936463 | ||
| Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma | Q44939914 | ||
| Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease | Q44983123 | ||
| Epstein-Barr virus gene expression in nasopharyngeal carcinoma | Q45205828 | ||
| The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. | Q45835618 | ||
| Geographical prevalence of two types of Epstein-Barr virus | Q45836134 | ||
| A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes | Q45837523 | ||
| Epstein-Barr virus-associated peripheral T-cell lymphoma of activated CD8 phenotype | Q45850601 | ||
| Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells | Q45863090 | ||
| EBV strain variation: geographical distribution and relation to disease state | Q46160576 | ||
| Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease | Q69328485 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 6303-6308 | |
| P577 | publication date | 1993-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas | |
| P478 | volume | 67 |
| Q40032608 | A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. |
| Q35872919 | A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle |
| Q33748089 | Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo |
| Q35147016 | CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation |
| Q34502958 | Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line |
| Q40684609 | Detection and characterization of Epstein-Barr virus in clinical specimens. |
| Q35798521 | Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders |
| Q40041854 | Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes. |
| Q30837949 | EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas |
| Q38257974 | Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis |
| Q35757197 | Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associat |
| Q45746241 | Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1. |
| Q45753650 | Epstein-Barr virus in the pathogenesis of Hodgkin's disease |
| Q41594644 | Epstein-Barr virus oncogenesis |
| Q35115666 | Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. |
| Q45733926 | Evidence of Epstein-Barr virus infection in ulcerative colitis |
| Q39599529 | Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV. |
| Q36327458 | Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice |
| Q39683879 | Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation |
| Q33640213 | IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter |
| Q38300664 | Increased number of Epstein-Barr virus latently infected B-cells in T-cell non-Hodgkin's lymphoma tissues |
| Q35871457 | Infection of primary CD4+ and CD8+ T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression |
| Q35892261 | Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma. |
| Q39870487 | Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker |
| Q39556046 | Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR. |
| Q39683197 | Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas |
| Q39581267 | Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. |
| Q28213116 | Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin |
| Q39650776 | STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus–encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma |
| Q35874869 | The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element |
| Q33783746 | The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive |
| Q41553353 | The role of Epstein-Barr virus in lymphoid malignancies |
| Q35854017 | Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein |
| Q35798133 | Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia |
| Q45727288 | Unique Epstein–Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection |
Search more.